LOPIANO, Leonardo
LOPIANO, Leonardo
NEUROSCIENZE "RITA LEVI MONTALCINI"
3 years comparison between duodopa and Deep Brain Stimulation
2012-01-01 Artusi, C.A.; Merola, A.; Zibetti, M.; Marchisio; Angrisano, S.; Rizzi, L.; Lanotte, M.M.; Rizzone, M.G.; Lopiano, L.
80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements.
2013-01-01 Merola A.; Zibetti M.; Artusi C.A.; Rizzi L.; Angrisano S.; Lanotte M.; Lopiano L.; Rizzone M.G.
Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients
2017-01-01 Rosa, Manuela; Arlotti, Mattia; Marceglia, Sara; Cogiamanian, Filippo; Ardolino, Gianluca; Fonzo, Alessio Di; Lopiano, Leonardo; Scelzo, Emma; Merola, Aristide; Locatelli, Marco; Rampini, Paolo M.; Priori, Alberto
Advanced therapies in Parkinson's disease: Long-term retrospective study
2016-01-01 Merola, Aristide; Espay, Alberto J.; Romagnolo, Alberto; Bernardini, Andrea; Rizzi, Laura; Rosso, Michela; Espay, Kristy J.; Zibetti, Maurizio; Lanotte, Michele; Lopiano, Leonardo
Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo.
2009-01-01 Castelli L.; Rizzi L.; Molinaro S.; Tonello D.; Cornero P.; Zibetti M.; Lanotte M.; Ardito R.B.; Lopiano L.
Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study
2014-01-01 Lorys Castelli; Debora Tonello; Laura Rizzi; Maurizio Zibetti; Michele Lanotte; Leonardo Lopiano
Alpha-synuclein and Parkinson's disease: a proteomic view.
2008-01-01 M. Fasano;L. Lopiano
Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity
2006-01-01 COLAPINTO M; MILA S; GIRAUDO S; STEFANAZZI P; MOLTENI M; ROSSETTI C; BERGAMASCO B; LOPIANO L; FASANO M
“Alterazioni comportamentali nella malattia di Parkinson: procedura chirurgica, stimolazione, malattia?”
2005-01-01 Lopiano L; Castelli L.
AN ORIGINAL STUDY OF MASTICATION IN PATIENTS WITH ADVANCED PARKINSON DISEASE WITH AND WITHOUT ME- DICAL THERAPY AND DEEP BRAIN STIMULATION
2012-01-01 M. Piancino; T. Vallelonga; F. Talpone; M. Zibetti; L. Lopiano; C. Leocata; E. Comino; M. Incardona; P. Bracco; A. Deregibus; C. Debernardi
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation
2010-01-01 Piancino M.G.; Zibetti M.; Azzaro C.; Talpone F.; Vallelonga T.; Altieri E.; Lopiano L.; Debernardi C.; Bracco P
An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation.
2010-01-01 Piancino M.G.; Zibetti M.; Azzaro C.; Talpone F.; Vallelonga T.; Lanotte M.; Altieri E.; Lopiano L.; Debernardi C.; Bracco P.
Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani.
2002-01-01 GERZELI S; CAVALLO M.C; CAPRARI F; PONZI P; GRUPPO DI STUDIO DBS ALBANESE A; AMMANNATI F; CAPUS L; M. LANOTTE; LOPIANO L; MELATINI S; MAZZONE P; SCERRATI M; STANZIONE P; MORETTI V; PEPPE A; PIERANTOZZI M; RIZZONE M; ROMITO L.A; SCOTTO DI LUZIO A
Analysis of CHCHD2 and CHCHD10 genes in patients with Parkinson’s disease and mitochondrial myopathy.
2017-01-01 E. Rubino; S. Boschi; M. Zhang; L. Brusa; F. Govone; A. Vacca; A. Gai; L. Lopiano; E. Rogaeva; T. Mongini; M. Giordana; I. Rainero;
Analysis of Sleep Pattern after Duodenal Levodopa Infusion in Advanced Parkinson’s Disease
2012-01-01 E. Cavallo; E. Peila; M. Zibetti; D. Mannina; A. Robert; G.Z.Zacchi; S. Angrisano; L. Lopiano; A. Cicolin
Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study.
2009-01-01 G. Santangelo;L. Morgante;R. Savica;R. Marconi;L. Grasso;A. Antonini;D. D. Gaspari;D. Ottaviani;D. Tiple;L. Simoni;P. Barone;P. R. I.; L. Lopiano (collaborator)
Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis
2008-01-01 ZIBETTI M; PESARE M; CINQUEPALMI A; ROSSO M; BERGAMASCO B; DUCATI A; LANOTTE M; LOPIANO L
Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic
2021-01-01 Montanaro E.; Artusi C.A.; Rosano C.; Boschetto C.; Imbalzano G.; Romagnolo A.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L.
Apathy and verbal fluency in STN-stimulated PD patients
2006-01-01 Castelli L; Zibetti M ; Caglio M ; Lanotte M ; Bergamasco B; Lopiano L.
Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study
2007-01-01 Castelli L; Lanotte M; Zibetti M; Caglio M; Rizzi L; Ducati A.; Bergamasco B; Lopiano L.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3 years comparison between duodopa and Deep Brain Stimulation | 2012 | Artusi, C.A.; Merola, A.; Zibetti, M.; Marchisio; Angrisano, S.; Rizzi, L.; Lanotte, M.M.; Rizzone, M.G.; Lopiano, L. | |
| 80 Hz versus 130 Hz subthalamic nucleus deep brain stimulation: effects on involuntary movements. | 2013 | Merola A.; Zibetti M.; Artusi C.A.; Rizzi L.; Angrisano S.; Lanotte M.; Lopiano L.; Rizzone M.G. | |
| Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients | 2017 | Rosa, Manuela; Arlotti, Mattia; Marceglia, Sara; Cogiamanian, Filippo; Ardolino, Gianluca; Fonzo, Alessio Di; Lopiano, Leonardo; Scelzo, Emma; Merola, Aristide; Locatelli, Marco; Rampini, Paolo M.; Priori, Alberto | |
| Advanced therapies in Parkinson's disease: Long-term retrospective study | 2016 | Merola, Aristide; Espay, Alberto J.; Romagnolo, Alberto; Bernardini, Andrea; Rizzi, Laura; Rosso, Michela; Espay, Kristy J.; Zibetti, Maurizio; Lanotte, Michele; Lopiano, Leonardo | |
| Alessitimia e depressione in pazienti con malattia di Parkinson sottoposti a deep brain stimulation del subtalamo: uno studio caso-controllo. | 2009 | Castelli L.; Rizzi L.; Molinaro S.; Tonello D.; Cornero P.; Zibetti M.; Lanotte M.; Ardito R.B.; Lopiano L. | |
| Alexithymia in patients with Parkinson's disease treated with DBS of the subthalamic nucleus: a case-control study | 2014 | Lorys Castelli; Debora Tonello; Laura Rizzi; Maurizio Zibetti; Michele Lanotte; Leonardo Lopiano | |
| Alpha-synuclein and Parkinson's disease: a proteomic view. | 2008 | M. Fasano;L. Lopiano | |
| Alpha-Synuclein protects SH-SY5Y cells from dopamine toxicity | 2006 | COLAPINTO M; MILA S; GIRAUDO S; STEFANAZZI P; MOLTENI M; ROSSETTI C; BERGAMASCO B; LOPIANO L; FASANO M | |
| “Alterazioni comportamentali nella malattia di Parkinson: procedura chirurgica, stimolazione, malattia?” | 2005 | Lopiano L; Castelli L. | |
| AN ORIGINAL STUDY OF MASTICATION IN PATIENTS WITH ADVANCED PARKINSON DISEASE WITH AND WITHOUT ME- DICAL THERAPY AND DEEP BRAIN STIMULATION | 2012 | M. Piancino; T. Vallelonga; F. Talpone; M. Zibetti; L. Lopiano; C. Leocata; E. Comino; M. Incardona; P. Bracco; A. Deregibus; C. Debernardi | |
| An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation | 2010 | Piancino M.G.; Zibetti M.; Azzaro C.; Talpone F.; Vallelonga T.; Altieri E.; Lopiano L.; Debernardi C.; Bracco P | |
| An original study of mastication in patients with advanced Parkinson disease with and without therapy and deep brain stimulation. | 2010 | Piancino M.G.; Zibetti M.; Azzaro C.; Talpone F.; Vallelonga T.; Lanotte M.; Altieri E.; Lopiano L.; Debernardi C.; Bracco P. | |
| Analisi dei costi della stimolazione cerebrale profonda (DBS) nella malattia di Parkinson: uno studio osservazionale su pazienti italiani. | 2002 | GERZELI S; CAVALLO M.C; CAPRARI F; PONZI P; GRUPPO DI STUDIO DBS ALBANESE A; AMMANNATI F; CAPUS L; M. LANOTTE; LOPIANO L; MELATINI S; MAZZONE P; SCERRATI M; STANZIONE P; MORETTI V; PEPPE A; PIERANTOZZI M; RIZZONE M; ROMITO L.A; SCOTTO DI LUZIO A | |
| Analysis of CHCHD2 and CHCHD10 genes in patients with Parkinson’s disease and mitochondrial myopathy. | 2017 | E. Rubino; S. Boschi; M. Zhang; L. Brusa; F. Govone; A. Vacca; A. Gai; L. Lopiano; E. Rogaeva; T. Mongini; M. Giordana; I. Rainero; | |
| Analysis of Sleep Pattern after Duodenal Levodopa Infusion in Advanced Parkinson’s Disease | 2012 | E. Cavallo; E. Peila; M. Zibetti; D. Mannina; A. Robert; G.Z.Zacchi; S. Angrisano; L. Lopiano; A. Cicolin | |
| Anhedonia and cognitive impairment in Parkinson's disease: Italian validation of the Snaith-Hamilton Pleasure Scale and its application in the clinical routine practice during the PRIAMO study. | 2009 | G. Santangelo;L. Morgante;R. Savica;R. Marconi;L. Grasso;A. Antonini;D. D. Gaspari;D. Ottaviani;D. Tiple;L. Simoni;P. Barone;P. R. I.; L. Lopiano (collaborator) | |
| Antiparkinsonian therapy modifications in PD patients after STN DBS: A retrospective observational analysis | 2008 | ZIBETTI M; PESARE M; CINQUEPALMI A; ROSSO M; BERGAMASCO B; DUCATI A; LANOTTE M; LOPIANO L | |
| Anxiety, depression, and worries in advanced Parkinson disease during COVID-19 pandemic | 2021 | Montanaro E.; Artusi C.A.; Rosano C.; Boschetto C.; Imbalzano G.; Romagnolo A.; Bozzali M.; Rizzone M.G.; Zibetti M.; Lopiano L. | |
| Apathy and verbal fluency in STN-stimulated PD patients | 2006 | Castelli L; Zibetti M ; Caglio M ; Lanotte M ; Bergamasco B; Lopiano L. | |
| Apathy and verbal fluency in STN-stimulated PD patients: An observational follow-up study | 2007 | Castelli L; Lanotte M; Zibetti M; Caglio M; Rizzi L; Ducati A.; Bergamasco B; Lopiano L. |